It's the second time in two years that rumors about Fosun Chairman Guo Guangchang's whereabouts stirred the market.

Bristol-Myers Squibb will unload an API plant in Ireland to a South Korean company with large aspirations in contract manufacturing.

Bharat Biotech has initiated a phase 1 trial of its Chikungunya vaccine, while Themis started a phase 2 of its own candidate.

Serum Institute of India CEO Adar Poonawalla struck a deal on Tuesday to pick up a defunct Czech outfit for €72 million.

Takeda is letting go of 180 of the nearly 300 employees picked up in its $5.2 billion buyout of Ariad but says some of those may still land jobs in its global…

The race to snatch up generics maker Stada is heating up—and fast—with multiple players reportedly preparing to jump in, including Chinese drugmakers and,…

Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.

Piramal added to its run of healthcare acquisitions with a $175 million deal to buy five injectable pain drugs from Johnson & Johnson.

More than two years after buying Merck's OTC unit and local player Dihon, bringing together three separate consumer care businesses in China remains a…